Legal Representation
Attorney
Pam Kohli Jacobson
USPTO Deadlines
Next Deadline
1122 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-08-09)
Due Date
August 09, 2028
Grace Period Ends
February 09, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
34 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 1, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Dec 1, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 1, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Aug 9, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Aug 9, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Jul 2, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jul 1, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Apr 18, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Apr 18, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Apr 1, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Apr 1, 2022 | IUAF | S | USE AMENDMENT FILED |
| Sep 16, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 14, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Sep 14, 2021 | EXT2 | S | SOU EXTENSION 2 FILED |
| Sep 14, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Mar 9, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 5, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 5, 2021 | EXT1 | S | SOU EXTENSION 1 FILED |
| Mar 5, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Oct 6, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Aug 11, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 11, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jul 22, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 9, 2020 | FIXD | O | ELECTRONIC RECORD REVIEW COMPLETE |
| Jul 3, 2020 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Jun 29, 2020 | ALIE | A | ASSIGNED TO LIE |
| Jun 26, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 26, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jun 26, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jun 26, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 26, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 24, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 16, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 9, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medical and pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; pharmaceutical and natural remedy preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; pharmaceutical drugs for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases; pharmaceutical preparations for the treatment of kidney diseases, liver diseases, immune system diseases and inflammatory diseases
First Use Anywhere:
Dec 15, 2021
First Use in Commerce:
Dec 15, 2021
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...